Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Bioequivalence Study of Exemestane 25 mg Tablets Under Fasting Conditions in Healthy Subjects

NCT01760980 is registered in ClinicalTrials.gov with Actavis Inc. as lead sponsor.

NCT NCT01760980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01760980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Bioequivalence Study of Exemestane 25 mg Tablets Under Fasting Conditions in Healthy Subjects
Lead sponsor
Actavis Inc.
Phase
Phase 1
Overall status
Withdrawn
Start date
November 30, 2012
Completion date
December 31, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy